ScholarIQanswers from OpenAlex & ORCID
Anders Olsson
ResearcherPublications, citations & collaboration network
Anders Olsson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anders Olsson have?
ScholarIQindexed works
Anders Olsson has 644 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anders Olsson have?
ScholarIQcitation count
Anders Olsson has 32,149 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anders Olsson?
ScholarIQh-index
Anders Olsson has an h-index of 73 in OpenAlex.
What is the i10-index of Anders Olsson?
ScholarIQi10-index
Anders Olsson has an i10-index of 210 in OpenAlex.
What is the ORCID of Anders Olsson?
ScholarIQorcid
The ORCID for Anders Olsson is on the source record.
What is the OpenAlex record for Anders Olsson?
ScholarIQopenalex
The OpenAlex for Anders Olsson is on the source record.
What are the most-cited papers on Anders Olsson?
ScholarIQmost cited works
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Anders Olsson, John J.V. McMurray, G Thorgeirsson, Christian Spaulding, Jim Slattery, Kalevi Pyörälà, Ole Færgeman, R. Scott Wright, Katherine M. Berg, Lars Wilhelmsen, T.R. Pedersen, T. A. Miettinen, HD White, John Kjekshus, Michael Gnant
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz, Anders Olsson, Markus Abt, Christie M. Ballantyne, Philip J. Barter, Jochen Brumm, Bernard Chaitman, Ingar Holme, David Kallend, Lawrence A. Leiter, Eran Leitersdorf, John J.V. McMurray, Hardi Mundl, Stephen J. Nicholls, Prediman K. Shah, Jean‐Claude Tardif, R. Scott Wright
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
Kalevi Pyörälà, Terje R. Pedersen, John Kjekshus, Ole Færgeman, Anders Olsson, Guðmundur Þorgeirsson, The Scandinavian Simvastatin Survival Study (4S) Group